BEMTUVIQ

Swiss trademark · 836172 · Combined mark · In force

Register entry

Registration number
836172
Application number
10798/2025
Status
In force
Type
Combined mark
As registered
BEMTUVIQ ((fig.))
Filed
Jul 23, 2025
Registered
Sep 11, 2025
Published
Sep 11, 2025
Protected until
Jul 23, 2035
Colours claimed
Dunkelgrün, grün, orange.
Language of procedure
German
Vienna classes
26.04.04, 26.04.09
Source
Swissreg

Goods and services

Pharmaceuticals

Pharmazeutische Präparate und Substanzen zur Behandlung von Krebs sowie von Herz-Kreislauf-Erkrankungen und - Störungen; pharmazeutische Präparate und Substanzen zur Behandlung von onkologischen Erkrankungen und onkologischen Störungen; pharmazeutische Präparate zur Behandlung von Magen- und gastroösophageale Erkrankungen oder Beschwerden.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 11, 2025

    Registered

    Published in Swissreg on 11.09.2025

Parties

Holder

Amgen Inc.

AMGEN INC.

One Amgen Center Drive, Thousand Oaks, California 91320-1799, US

Agent

WEINMANN ZIMMERLI

Carmenstrasse 28, 8032 Zürich

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.